Medical Developments International Ltd
ASX:MVP

Watchlist Manager
Medical Developments International Ltd Logo
Medical Developments International Ltd
ASX:MVP
Watchlist
Price: 0.605 AUD 4.31% Market Closed
Market Cap: 68.2m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+35%
Revenue
Forecast
+15%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

MVP Price Targets Summary
Medical Developments International Ltd

Wall Street analysts forecast MVP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MVP is 0.816 AUD with a low forecast of 0.808 AUD and a high forecast of 0.84 AUD.

MVP Lowest Forecast
Wall Street Target
0.808 AUD
34% Upside
MVP Average Forecast
Wall Street Target
0.816 AUD
35% Upside
MVP Highest Forecast
Wall Street Target
0.84 AUD
39% Upside
Lowest
Price Target
0.808 AUD
34% Upside
Average
Price Target
0.816 AUD
35% Upside
Highest
Price Target
0.84 AUD
39% Upside
Medical Developments International Ltd Competitors:
Price Targets
1177
Sino Biopharmaceutical Ltd
15% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
14% Upside
SANOFI
Sanofi India Ltd
28% Upside
ALKEM
Alkem Laboratories Ltd
2% Upside
1177
Sino Biopharmaceutical Ltd
15% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
14% Upside
SANOFI
Sanofi India Ltd
28% Upside
ALKEM
Alkem Laboratories Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Medical Developments International Ltd

For the last 8 years the compound annual growth rate for Medical Developments International Ltd's revenue is 10%. The projected CAGR for the next 3 years is 15%.

10%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Medical Developments International Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Medical Developments International Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
What are analyst estimates?

See Also

Summary
MVP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MVP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MVP stock valuation using valuation multiples.
Wall Street Estimates
MVP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MVP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MVP's stock price target?
Price Target
0.816 AUD

According to Wall Street analysts, the average 1-year price target for MVP is 0.816 AUD with a low forecast of 0.808 AUD and a high forecast of 0.84 AUD.

What is Medical Developments International Ltd's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Medical Developments International Ltd's revenue is 10%. The projected CAGR for the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.